| Uniprot ID: | P10451 |
| Secondary ID: | B2RDA1 |
| Symbol: | SPP1 |
| Other Name: | BNSP,Bone sialoprotein 1,Nephropontin,Secreted phosphoprotein 1,SPP-1,Urinary stone protein,Uropontin |
| Class: | Single Protein |
| Type: | pro-fibrotic |
| Molecular Function: | Cytokine |
| Category I | Category II | Category III |
|---|---|---|
| Extracellular | Other |
Reference Record 1
| PubMed ID | 28595626 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Pulmonary fibrosis |
| Process I | |||
| Process II | fibroblasts activation,myofibroblasts differentiation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting TGF-β1 signaling | ||
Reference Record 2
| PubMed ID | 24902765 | Compound ID | |
| CAS | Name | ||
| Model | vitro,human,mice | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 3
| PubMed ID | 24871103 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Liver fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 4
| PubMed ID | 22858059 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 5
| PubMed ID | 22661273 | Compound ID | |
| CAS | Name | ||
| Model | vitro,human | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | HSCs activation,HSCs proliferation | ||
| Process III | |||
| Mechanism | Targeting TGF-β1 | ||
Reference Record 6
| PubMed ID | 22402440 | Compound ID | |
| CAS | Name | ||
| Model | human,mice | Fibrosis Disease | Systemic sclerosis |
| Process I | attenue inflammation | ||
| Process II | myofibroblasts differentiation,fibroblasts migration,myofibroblasts accumulation | ||
| Process III | |||
| Mechanism | |||
Reference Record 7
Reference Record 8
| PubMed ID | 21953216 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Scar |
| Process I | attenue inflammation | ||
| Process II | HSCs proliferation,HSCs migration | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 9
| PubMed ID | 21953216 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Liver fibrosis |
| Process I | attenue inflammation | ||
| Process II | HSCs proliferation,HSCs migration | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 10
| PubMed ID | 21734100 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Renal fibrosis |
| Process I | attenue inflammation | ||
| Process II | EMT,fibroblasts proliferation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 11
| PubMed ID | 21525025 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 12
| PubMed ID | 20967826 | Compound ID | |
| CAS | Name | ||
| Model | vitro,human,mice | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | HSCs activation,myofibroblasts differentiation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 13
| PubMed ID | 20720406 | Compound ID | |
| CAS | Name | ||
| Model | rat | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 14
| PubMed ID | 20200330 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 15
| PubMed ID | 19720619 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Pulmonary fibrosis |
| Process I | attenue inflammation | ||
| Process II | myofibroblasts accumulation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 16
| PubMed ID | 19451692 | Compound ID | |
| CAS | Name | ||
| Model | vitro,human,mice | Fibrosis Disease | Muscle fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 17
| PubMed ID | 19246678 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 18
| PubMed ID | 16128620 | Compound ID | |
| CAS | Name | ||
| Model | vitro,human | Fibrosis Disease | Idiopathic pulmonary fibrosis |
| Process I | |||
| Process II | fibroblasts proliferation,fibroblasts migration | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||